Forward Pharma A/S
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FWPAY research report →
Price Chart
About the company
Forward Pharma A/S presently engages in very limited business activities. In the past, this biopharmaceutical firm concentrated its efforts on developing FP187, its distinctive formulation of dimethyl fumarate, which was aimed at addressing both inflammatory and neurological conditions. The company was founded in 2005 and its headquarters are located in Copenhagen, Denmark.
- CEO
- Claus Bo Søndergaard Svendsen
- IPO
- 2014
- Employees
- 4
- HQ
- Copenhagen, DK
Get TickerSpark's AI analysis on FWPAY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $7.45M
- P/E
- 2166.67
- PEG
- 21.67
- P/S
- 0.00
- P/B
- 2.69
- EV/EBITDA
- 37.40
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- 2060.64%
- Net Margin
- -47.87%
- ROE
- 0.12%
- ROIC
- 0.26%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-3,874,000
- Net Income
- $-1,892,000+70.7%
- EPS
- $-77.41+71.2%
- OCF Growth
- +58.7%
- FCF Growth
- +58.7%
- 52W High
- $882.86
- 52W Low
- $200.00
- 50D MA
- $417.99
- 200D MA
- $548.55
- Beta
- 1.02
- RSI (14)
- 9
- Avg Volume
- 11
No earnings-call transcripts are available for FWPAY yet.
- Free Float
- 319176.0%
- Shares Outstanding
- 24.82K
- Float Shares
- 79.22M
Our FWPAY coverage
Recent articles, reports, and earnings notes.
No research on FWPAY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FWPAY report →Uranium Energy (UEC) Exceeds Market Returns: Some Facts to Consider
https://www.zacks.com · May 20
BlackRock (BLK) Stock Sinks As Market Gains: Here's Why
https://www.zacks.com · May 20
Forward Pharma A/S Announces Termination of its American Depositary Receipts (“ADR”) Facility
globenewswire.com · Jan 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.